JHS Svendgaard Laboratories Limited
NSE: JHSLive • NSE
Day range
52 week range
JHS Svendgaard Laboratories Limited closed at INR9.47 (+4.99%) on volume 0.14x its 20-day average, trading 31.87% below its 52-week high.
2026-Q1
Q1 FY2026 Financial Results
PAT moved -552.4% QoQ
2023-09-11
OTHER Announced
Demerger
2019-09-06
AGM Announced
Annual General Meeting
Revenue and PAT bars use independent scales to make their year-on-year direction readable.
Complete reported financial history · Values use the company's reporting currency
Hover over the chart for exact reported values. Percentage lines use the right-hand axis.
A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.
Strengths
Low Debt Profile: Debt-to-Equity is comfortable at 0.09x
Risks
Subject to cyclical raw material and macro industry pressures
Bull case
Market Leadership: Established operational scale in Household & Personal Products.
Bear case
Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.
Flip condition
Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.
Complete dividend, bonus, split, rights and other action history
| Record date | Corporate action | Information | Announcement date | Ex-date |
|---|---|---|---|---|
| 11 Sept 2023 | Demerger | Demerger | — | 11 Sept 2023 |
| — | Annual General Meeting | Annual General Meeting | — | 06 Sept 2019 |
| — | Annual General Meeting | Annual General Meeting | — | 03 Sept 2018 |
| — | Annual General Meeting | Annual General Meeting | — | 21 Aug 2017 |
| — | Extra Ordinary General Meeting | Extra Ordinary General Meeting | — | 02 Jan 2017 |
| — | Annual General Meeting | Annual General Meeting | — | 11 Aug 2016 |
| — | Annual General Meeting | Annual General Meeting | — | 21 Aug 2015 |
Traded volume and delivery percentage across the latest 20 sessions
Compare valuation, latest quarterly performance and year-on-year growth
| Company name | Market cap ₹ Cr | P/E ratio | Dividend yield % | Quarterly sales ₹ Cr | Profit after tax ₹ Cr | Sales growth % | Profit growth % |
|---|---|---|---|---|---|---|---|
 Hindustan Unilever LimitedHINDUNILVR Open analysis | ₹4.45L | 42.46 | 2.32% | ₹17,341.00 | ₹2,680.00 | +10.05% | -3.18% |
 ITC LimitedITC Open analysis | ₹3.30L | 16.64 | 6.06% | ₹19,114.00 | ₹4,509.00 | -11.08% | -15.61% |
 Nestlé India LimitedNESTLEIND Open analysis | ₹2.44L | 59.83 | 0.94% | ₹6,378.00 | ₹959.00 | +25.16% | +48.22% |
 Avenue Supermarts LimitedDMART Open analysis | ₹2.18L | 69.89 | 0.00% | ₹18,795.00 | ₹860.00 | +14.88% | +11.25% |
 Varun Beverages LimitedVBL Open analysis | ₹1.46L | 43.05 | 0.47% | ₹8,451.00 | ₹1,525.00 | +20.44% | +15.09% |
 Britannia Industries LimitedBRITANNIA Open analysis | ₹1.15L | 44.07 | 1.87% | ₹5,000.00 | ₹593.00 | +8.18% | +14.04% |
 Marico LimitedMARICO Open analysis | ₹1.02L | 53.91 | 0.51% | ₹3,957.00 | ₹652.00 | +22.85% | +27.10% |
 UNITED SPIRITS LIMITEDUNITDSPR Open analysis | ₹97,987.65 | 58.11 | 1.23% | ₹3,054.00 | ₹539.00 | +3.67% | +28.03% |
JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures, trades in, and sells a range of oral and dental products in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, whitening gels, talcum powders, sanitizers, detergents, and denture tablets. It also provides contract manufacturing services for oral care products. In addition, the company exports its products. JHS Svendgaard Laboratories Limited was founded in 1997 and is based in New Delhi, India.
IndiaConsumer Defensive
Is JHS Svendgaard Laboratories Limited Shariah compliant?
JHS Svendgaard Laboratories Limited is currently screened as Shariah Compliant under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (17.94%) complies with AAOIFI threshold (≤ 33%).
What is JHS Svendgaard Laboratories Limited's current valuation relative to peers?
JHS Svendgaard Laboratories Limited trades at a P/E of N/A compared to the sector median of 21.9x, and a Price-to-Book of 0.5x.
Is the company financially healthy?
The company has a Debt-to-Equity ratio of 0.09x. Interest coverage is -5.7x.
What are the historical revenue and profit growth rates?
Over the past 5 years, revenue compounded at -6.3% while net profit growth averaged consistent levels.
Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.
Market data may be delayed. Quote date: 2026-10-19. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.